12 results
DEF 14A
TSBX
Turnstone Biologics Corp
22 Apr 24
Definitive proxy
4:28pm
has determined that Mr. Waddill qualifies as an “audit committee financial expert” within the meaning of the SEC regulations and meets the financial
8-K
EX-99.1
TSBX
Turnstone Biologics Corp
21 Mar 24
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights
5:14pm
recognized cancer immunotherapy expert, Dr. Jeffrey S. Weber
SAN DIEGO, Mar. 21, 2024 – Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq
424B4
TSBX
Turnstone Biologics Corp
21 Jul 23
Prospectus supplement with pricing info
7:14pm
financial expert within the meaning of the SEC regulations and meets the financial sophistication requirements of the applicable listing standards
S-1/A
yvfizv6nbdlqo3
23 Jun 23
IPO registration (amended)
9:49pm
S-1
n6sj2465iyx
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.8
8vd5hz9ef a3z70f7a4
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
q6by fm2xtg2rp
12 Jun 23
IPO registration
4:28pm
DRS
EX-2.1
hb2f4 may49lu
15 May 23
Draft registration statement
12:00am
DRS
EX-10.8
no3 596lay1
15 May 23
Draft registration statement
12:00am
DRS
2g9 b0ckn4o
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next